Follow The Filings

NPKI NPK International

NPK International earnings company data as of 5:01 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.13 — —
Rev — — —

Insider trades

Open-market buys and sales by NPKI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NPKI insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $5.6M sold by 7 insiders under 10b5-1 plans
  1. Matthew James Warren Chief Accounting Officer
    Planned sale
    $40K 2,991 shares at $13.41 5.5% of stake
    Traded Sep 9 Filed Sep 10
  2. Rose M Robeson Director
    Planned sale
    $135K 10,000 shares at $13.49 4.4% of stake
    Traded Aug 27 Filed Aug 31
  3. Michael A Lewis Director
    Planned sale
    $29K 2,013 shares at $14.26 1.5% of stake
    Traded Aug 17 Filed Aug 19
  4. Lori Briggs VP & President, Ind. Solutions
    Planned sale
    $123K 8,325 shares at $14.75 3.3% of stake
    Traded Jun 8 Filed Jun 9
  5. Matthew Lanigan CEO
    Planned sale
    $2.4M 167,375 shares at $14.43 40% of stake
    Traded Jun 3 Filed Jun 5
  6. Lori Briggs VP & President, Ind. Solutions
    Planned sale
    $152K 10,446 shares at $14.58 3.9% of stake
    Traded Jun 2 Filed Jun 3
  7. Michael A Lewis Director
    Planned sale
    $31K 2,013 shares at $15.30 1.5% of stake
    Traded May 15 Filed May 19
  8. Gregg Piontek CFO
    Planned sale
    $226K 15,000 shares at $15.05 1.8% of stake
    Traded Apr 9 Filed Apr 10
  9. Gregg Piontek CFO
    Planned sale
    $508K 35,000 shares at $14.51 4% of stake
    Traded Apr 1 Filed Apr 3
  10. Gregg Piontek CFO
    Planned sale
    $225K 15,000 shares at $15.03 1.7% of stake
    Traded Mar 25 Filed Mar 26
  11. Mary Celeste Fruge VP, General Counsel
    Planned sale
    $14K 1,000 shares at $13.56 0.4% of stake
    Traded Mar 16 Filed Mar 18
  12. Mary Celeste Fruge VP, General Counsel
    Planned sale
    $149K 11,193 shares at $13.34 4% of stake
    Traded Mar 6 Filed Mar 10
  13. Gregg Piontek CFO
    Planned sale
    $1.5M 108,590 shares at $14.07 11% of stake
    Traded Mar 4 Filed Mar 5
  14. Michael A Lewis Director
    Planned sale
    $29K 2,013 shares at $14.31 1.5% of stake
    Traded Feb 23 Filed Feb 25
  15. Michael A Lewis Director
    Planned sale
    $24K 2,013 shares at $12.00 1.5% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 12 share withholdings for taxes, and 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 5.02,9.01
8-K 5.02,9.01
SCHEDULE 13G —
10-Q
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
8-K 5.02,9.01
8-K 5.07,9.01
10-Q
8-K 7.01,9.01
8-K 2.02,9.01
SCHEDULE 13G/A —
DEF 14A
DEFA14A
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.